Targets Conference Showcases Exciting Data from Clinical Trials of Innovative Cancer Therapeutics
There has been an explosion in the number of cancer therapeutics and clinical trials in the recent past, owing...
There has been an explosion in the number of cancer therapeutics and clinical trials in the recent past, owing...
As October comes to a close, it’s time for our latest edition of Editors’ Picks. This monthly staple is...
Sports are often referred to as a metaphor for life. But, for ESPN reporter Holly Rowe, sports are quite...
In the effort to include more diverse patient populations in clinical trials, good intentions can easily go awry. Panelists...
As a monthly staple on this blog, we feature the editors’ picks from the 10 journal issues published by...
Rare cancers, when taken all together, make up an estimated 20 to 25 percent of all cancers diagnosed. With...
One of the world’s largest cancer research conferences, the AACR Annual Meeting 2019, came to an end with a...
Over the course of AACR Annual Meeting 2019, there were 213 presentations on incredibly exciting clinical trials. This is...
In the past couple of decades, progress against cancer has created a new generation of survivors. Today, more than...
About 80 percent of lung cancers are non-small cell lung cancers (NSCLC), and about 15 to 20 percent of...